Kenvue is considering selling some of its skin health and beauty brands to focus on core products. The company plans to retain bigger names like Neutrogena and Aveeno. Investment bankers at Goldman Sachs are assisting with the divestment process.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing